New combo therapy aims to tame Tough-to-Treat head & neck cancer recurrence
NCT ID NCT07277764
Summary
This study is testing a two-part treatment for recurrent nasopharyngeal cancer (a type of head and neck cancer) in patients who are not candidates for surgery. First, patients receive a short course of targeted radiation combined with an immunotherapy drug. After a break, they receive a longer, more standard course of radiation. The goal is to see if this approach is safe and effective at controlling the cancer and improving survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, 330029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.